Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.96 USD | +1.61% | +5.01% | +47.78% |
Mar. 07 | Kewaunee Scientific Shares Fall After Company Posts Lower Fiscal Q3 Net Sales | MT |
Mar. 06 | Earnings Flash (KEQU) KEWAUNEE SCIENTIFIC CORPORATION Posts Q3 Revenue $46.8M | MT |
Financials (USD)
Sales 2022 | 169M | Sales 2023 | 219M | Capitalization | 45.99M |
---|---|---|---|---|---|
Net income 2022 | -6M | Net income 2023 | - | EV / Sales 2022 | 0.44 x |
Net Debt 2022 | 34.36M | Net Debt 2023 | 33.62M | EV / Sales 2023 | 0.36 x |
P/E ratio 2022 |
-6.48
x | P/E ratio 2023 |
65
x | Employees | 982 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 74.33% |
1 day | +1.61% | ||
1 week | +5.01% | ||
1 month | +20.34% | ||
3 months | +50.21% | ||
6 months | +146.80% | ||
Current year | +47.78% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas Hull
CEO | Chief Executive Officer | 48 | 15-10-31 |
Donald Gardner
DFI | Director of Finance/CFO | 45 | 19-04-28 |
Mandar Ranade
CTO | Chief Tech/Sci/R&D Officer | 50 | 19-12-01 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Rhind
CHM | Chairman | 61 | 08-03-31 |
Donald Shaw
BRD | Director/Board Member | 73 | 13-05-31 |
Keith Gehl
BRD | Director/Board Member | 65 | 15-04-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 42.96 | +1.61% | 4,519 |
24-05-30 | 42.28 | +4.14% | 11,500 |
24-05-29 | 40.6 | +1.75% | 8,294 |
24-05-28 | 39.9 | -2.47% | 13,067 |
24-05-24 | 40.91 | -2.60% | 15,433 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+47.78% | 124M | |
+16.32% | 3.24B | |
+9.47% | 3.1B | |
+12.48% | 2.23B | |
+1.04% | 1.56B | |
+4.08% | 1.37B | |
-16.45% | 487M | |
+3.49% | 446M | |
-18.13% | 360M | |
-3.41% | 169M |
- Stock Market
- Equities
- KEQU Stock